Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|March 24, 2010
The M230L nonnucleoside reverse transcriptase inhibitor resistance mutation in HIV-1 reverse transcriptase impairs enzymatic function and viral replicative capacityHong-Tao Xu, Yudong Quan, Susan M Schader, et al.Antimicrobial Agents and Chemotherapy|May 29, 2014
Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitorsHong-Tao Xu, Susan P Colby-Germinario, Maureen Oliveira, et al.Antimicrobial Agents and Chemotherapy|November 30, 2011
In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirineSusan M Schader, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, et al.Journal of Virology|December 17, 2008
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1Dimitrios Coutsinos, Cédric F Invernizzi, Hongtao Xu, et al.Antimicrobial Agents and Chemotherapy|August 26, 2009
Human immunodeficiency virus type 1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirineHongtao Xu, Yudong Quan, Bluma G Brenner, et al.Retrovirology|August 19, 2018
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirMaureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.Journal of Virology|November 15, 2013
The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacityHong-Tao Xu, Susan P Colby-Germinario, Maureen Oliveira, et al.AIDS Research and Human Retroviruses|March 28, 2008
Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from CanadaMichel Ntemgwa, Thomas D'Aquin Toni, Bluma G Brenner, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
HIV-1 Group O Resistance Against Integrase InhibitorsAgnès Depatureaux, Thibault Mesplède, Peter Quashie, et al.Intervirology|May 22, 2013
HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restrictionIrene Lisovsky, Susan M Schader, Richard D Sloan, et al.Pageof 9